Mexico Regulator Cracks Down on E-Cigarette Sales Advertising

Dec.05.2022
Mexico Regulator Cracks Down on E-Cigarette Sales Advertising
Mexico increases surveillance on the sale of e-cigarettes and advertisements on social media. Detentions have already been made.

The regulatory body in Mexico has stated that advertisements on social media for the sale of electronic cigarettes or vaping devices are not the only means by which their sale can be detected. As a result, they have intensified their scrutiny of manufacturers and seized products.


The head of the Health Risk Protection Committee (Coepris) in Tamaulipas, Alberto Moctezuma Castillo, announced that they will be increasing their monitoring efforts due to complaints of illegal sales in other areas.


Last week we responded to citizens' complaints regarding the sale of electronic cigarettes in pharmacies. Although sales are prohibited, the pharmacies have obtained insurance and have begun the administrative process. Therefore, we are currently unable to provide more information," he commented.


The commissioner added that they also have information about the sale of these devices through social networks, which is the reason for their surveillance operation, particularly to prevent them from being sold to minors.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTSAPP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Italian anti-trust agency investigates PMI's marketing of smoke-free products, company denies wrongdoing
Italian anti-trust agency investigates PMI's marketing of smoke-free products, company denies wrongdoing
Italian anti-trust agency investigates Philip Morris International's promotion of smoke-free products, questioning potentially misleading language.
Oct.16 by 2FIRSTS.ai
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.
Oct.13
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
The Tuscaloosa, Alabama, City Council is considering imposing a local tax on e-cigarette products to meet a state bill deadline. Alabama Act 2025-377, signed into law in May, plans to impose a $0.10 per milliliter state excise tax on e-cigarette products starting in October.
Sep.25 by 2FIRSTS.ai
Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.
Nov.19
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Philip Morris International and Swedish Match Win Collective Lawsuit Over Zyn Nicotine Pouches
Philip Morris International and Swedish Match Win Collective Lawsuit Over Zyn Nicotine Pouches
In a recent victory, Philip Morris International and Swedish Match won a lawsuit concerning their product Zyn's pricing.
Sep.25 by 2FIRSTS.ai